A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

Clinical trial NCT04572243 · TERMINATED

Trial details

NCT number: NCT04572243
Sponsor: Eisai Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsies, Myoclonic

Start date: 2020-09-23
Primary completion: 2024-08-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.